SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is trending as community members express excitement over recent gains and its position as the 'face of Base,' with some drawing comparisons to early Shiba Inu and Dogecoin. Discussions include potential listings on major exchanges like Robinhood and Binance, which some believe could drive significant price appreciation. The community emphasizes holding for long-term gains, envisioning TOSHI reaching prices that could create millionaires.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging as the community discusses its partnership with OpenAI, with some drawing comparisons to Nvidia's earlier trajectory and anticipating further gains. The deal is viewed as a validation of AMD's technology in the AI space, though some analysts express concerns about potential dilution. Community members are actively debating the sustainability of the rally and potential price targets.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending with significant volume and after-hours gains, driven by recent partnerships with AI leaders like Nvidia, OpenAI, and Google. The community is buzzing with excitement about the stock's potential, viewing it as undervalued in the AI space and anticipating a sustained climb. Some speculate about a short squeeze, while others believe PATH could become the next major player in AI automation, drawing comparisons to Palantir.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around the meme coin, emphasizing its strong community and potential. Discussions highlight the resurgence of OG meme culture and the raw, unfiltered energy it represents, with many expressing bullish sentiment and urging others to 'RAGE harder.'

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull's stock, BULL, is trending amidst high trading volume, sparking discussions about a potential short squeeze. The community is comparing its borrow fee rate to GameStop's during the 2021 mega squeeze, while others point to institutional accumulation and a possible overreaction to the lock-up period expiration as drivers for the increased activity.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors discuss its potential transition to an AI/HPC data center business model and a possible gamma squeeze due to high short interest and open call options. Community members are highlighting analyst price target updates, YouTube coverage, and the company's competitive advantages in the energy sector. Some are comparing WULF to other AI-related stocks and anticipating a significant breakout.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as traders debate whether the stock's valuation is justified amid a broader discussion about a potential quantum computing bubble, particularly following recent reports questioning the sector. Bullish investors are encouraging buying the dips and highlighting long-term potential, while bears point to the company's financials and potential pullbacks.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending amidst volatile discussions about its valuation and future prospects in the quantum computing sector. While some traders express optimism, pointing to significant institutional investment and potential government contracts, others cite concerns about dilution, ongoing SEC investigations, and comparisons to other quantum stocks, leading to debates about a possible correction or pump and dump scenario.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

Universe Pharmaceuticals ($UPC) is trending due to discussions surrounding its low float and substantial cash reserves, leading to speculation about potential buybacks or strategic moves. The community is drawing comparisons to recent low-float bio stock runners, anticipating a similar breakout. Some traders are also highlighting the potential for a short squeeze.

Spell Token

SPELL is trending as the community discusses potential catalysts and future price predictions, with some eyeing a move towards "Pennyland". Sentiment is mixed, with some expressing frustration over price action while others are "stacking" and waiting for a breakout. Discussions include potential partnerships and speculation around upgrades.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can BMYs Neuroscience Portfolio Help to Diversify Its Business? 

Bristol Myers gains FDA Fast Track status for its Alzheimer's antibody BMS-986446 as Cobenfy drives early sales and pipeline momentum.

Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings

Pfizer's oncology strength, powered by Seagen's ADCs and key drugs like Xtandi and Lorbrena, is likely to be in focus ahead of Q3 earnings.

Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $44.66, denoting a -1.06% move from the preceding trading day.

Can Novo Nordisk's Restructuring Program Drive its Return to Growth?

NVO is cutting 9,000 jobs, targeting DKK 8 billion in savings, and shifting focus to obesity and diabetes R&D to regain growth momentum.

Can CYTK Clinch a Potential FDA Nod for Its Cardiovascular Drug?

Cytokinetics' aficamten shows superiority over metoprolol in late-stage oHCM trial, boosting investor confidence despite FDA delay.

Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know

Bristol Myers Squibb (BMY) reached $45.1 at the closing of the latest trading day, reflecting a +2.15% change compared to its last close.

Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor?

KRYS gains momentum with Vyjuvek's expanded FDA label and global approvals, while advancing a pipeline led by oncology candidate KB707.

The Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying organization, announced a new website on Monday that will connect patients with manufacturer-direct purchase programs.The website, AmericasMedicine.com, is scheduled to launch in January 2026, PhRMA <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://phrma.org/resources/phrma-announces-major-actions-as-part-of-industry-s-commitment-to-american-patients-and-workers">announced</a>. It will allow manufacturers to list a range of medicines and connect patients directly to available options prescribed by their doctor, it added. &nbsp;Pharmacy benefit managers (PBMs) and middlemen receive massive rebates on medicines while charging patients the full price, the organization noted. Direct purchase programs thus enable patients and employers to purchase medicines at a lower cost.The group represents several biopharmaceutical research companies, including Amgen (AMGN), Bristol Myers Squibb (BMY), and Merck (MRK). However, pharmaceutical manufacturers will make their own decisions to offer direct purchase programs, and if they want to participate in the new website, the group said.The announcement from the group coincides with the deadline set by President Trump for 17 pharmaceutical companies, including Amgen, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Roche unit Genentech, Gilead, GSK, Johnson &amp; Johnson, Novartis, Novo Nordisk, Regeneron, and Sanofi, to reduce drug prices in the U.S. to the levels paid by other wealthy countries.The group stated on Monday that it will continue to work with the Trump administration and Congress to address the real reasons U.S. medicine prices are higher.“To reduce price differentials with other wealthy countries, policymakers should require PBMs to share savings with patients, fix the 340B hospital markup program and force foreign governments to pay their fair share,” the lobby group said. It also noted that its member companies are making significant investments in U.S.-based manufacturing and infrastructure.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/datavault-ai-stock-jumpes-13-percent-after-announcing-partnetship-with-ibm/chDu22ZR3J9">Datavault AI Stock Jumps 13% After Announcing Partnership With IBM</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A photo illustration showing a mix of various tablets and pharmaceutical products, primarily manufactured by U.S. pharmaceutical companies, photographed in Edmonton, Alberta, Canada, on April 10, 2025 (Photo by Artur Widak/NurPhoto via Getty Images)

Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Programs

The announcement from the group coincides with the deadline set by President Trump for 17 pharmaceutical companies to reduce drug prices in the U.S. to the levels paid by other developed countries.

Equity

The announcement from the group coincides with the deadline set by President Trump for 17 pharmaceutical companies to reduce drug prices in the U.S. to the levels paid by other developed countries.


Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

BMY
Bristol-Myers Squibb Co.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BMY News

BMY Bristol-Myers Squibb Co.